Tuesday, March 17

Healthcare

ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements

08/29/20241 Min Read

compliance continued ENDRA extension granted life listing Nasdaq regain requirements Sciences

Previous ArticleDay One Biopharma files to sell 12.07M shares of common stock for holders

Next Article Roth starts CG Oncology at purchase, cites anticipated FDA filing